BIO4 Campus took part in the ASCO 2025 Annual Meeting in Chicago, the world’s largest and most influential oncology conference, held from May 29 to June 4. Representing Serbia’s emerging biomedical innovation ecosystem, Stefan Milosevic, AI & Bioinformatics Lead at BIO4 d.o.o., engaged with leading global researchers, pharmaceutical representatives, and cancer centers to position Serbia as a credible partner in oncology.

The annual ASCO gathering brought together tens of thousands of oncologists, researchers, and healthcare innovators under the theme “Driving Knowledge to Action: Building a Better Future” BIO4’s presence marked a significant step in internationalizing Serbia’s research potential and forming partnerships around digital twin technology, AI-driven clinical decision support, and multi-modal cancer data integration.

BIO4’s participation was supported by a shared mission to foster international collaboration, attract biomedical investment, and accelerate the clinical application of AI and omics technologies across the region.